期刊文献+

大鼠急性心肌梗死后心肌细胞凋亡和半胱天冬蛋白酶-3的表达及卡维地洛的防治作用 被引量:1

Beneficial Effects of Carvedilol on Cardiomyocyte Apoptosis and Caspase-3 Expression After Acute Myocardial Infarction in Rats
下载PDF
导出
摘要 目的 :研究大鼠急性心肌梗死后心肌细胞凋亡和半胱天冬蛋白酶 3 (Caspase 3 )的表达及卡维地洛的防治作用。  方法 :冠状动脉结扎术后 2 4h存活的雌性SD大鼠 83只随机分为心肌梗死对照组 (MI组 ,n =43 )和卡维地洛[10mg/(kg·d) ]治疗组 (C组 ,n =40 )两组 ,另设假手术组 (S组 ,n =2 7) ;最终血流动力学资料完整的上述各组大鼠数分别为 11、 13、 9、 15、 10和 10只。C组于术后 2 4h直接灌胃法给药。末端脱氧核苷酸转移酶介导的脱氧尿苷三磷酸缺口末端标记法 (TUNEL)和脱氧核糖核酸 (DNA)凝胶电泳检测心肌细胞凋亡。免疫组化方法和Western印迹法检测Cas pase 3的表达。  结果 :与S组相比 ,MI组的左心室收缩压 (LVSP)和左心室内压最大上升和下降速率 (±dp/dt)均显著降低 (P <0 0 5~ 0 0 1) ,左心室舒张末压 (LVEDP)均显著升高 (P <0 0 5~ 0 0 1) ,且 4W时升高更为显著 (P <0 0 1) ;梗死区或疤痕区、梗死边缘区和非梗死区的心肌细胞凋亡指数均显著升高 (P <0 0 5~ 0 0 1) ,Caspase 3表达也均显著增高 (P <0 0 5~ 0 0 1)。与MI组相比 ,C组 48h的LVSP、±dp/dt和心率均显著降低 (P <0 0 5~ 0 0 1) ,但LVEDP及上述各部位的心肌细胞凋亡指数和Caspase 3的表达均无显著变化 ;而C组 Objective:To investigate the beneficial effects of carvedilol on cardiomyocyte apoptosis and the expression of Caspase 3 after acute myocardial infarction (AMI) in rats. Methods:AMI model was established with the ligation of anterior descending coronary artery in female SD rats. Twenty four hours after operation, 83 survivors were randomly assigned to AMI control (MI, n Z =43) or carvedilol [10 mg/ (kg·d) ] treatment (C, n =40) group,with each being randomly reassigned to 48 hour and 4 week subgroups according to the time points: MI 48 h and MI 4 W, C 48 h and C 4 W. Sham operated (S, n =27) group was selected randomly, and also reassigned to S 48 h and S 4 W subgroups. The final rats number in each subgroup was 11,13,9,15,10,and 10, repectiely. Carvedilol was given to group C by gastric gavage 24 h after ligation. Cardiomyocyte apoptosis was detected with TUNEL and DNA ladder. Caspase 3 was detected with immunohistochemistry and Western blot analysis. Results:Compared with sham operated group, in MI 48 h and MI 4 W group, left ventricular systolic pressure (LVSP) and the maximum rate rise of left ventricular pressure (±dp/dt) were significantly decreased ( p <0 05—0 01) ,while left ventricular end diastolic pressure (LVEDP) was significantly increased ( p <0 05) ,even significantly higher at 4 weeks ( p <0 01) .Myocyte apoptotic index was also significantly increased in the infracted/scar, border and non infarcted areas ( p <0 05—0 01) ,with the significantly increased expression of Caspase 3 ( p <0 05—0 01) . Compared with MI group, LVEDP, myocyte apoptotic indices in the three areas and the expression of Caspase 3 were not significantly changed B ( p >0 05) in C 48 h group, only LVSP and ±dp/dt were significantly decreased ( p <0 05—0 01) .In C 4 W group, LVEDP, as well as the myocyte apoptotic indices in the scar and border areas were significantly decreased ( p <0 05—0 01) , but LVSP,±dp/dt and expression of Caspase 3 were not significantly changed ( p >0 05) . Conclusions:As abnormal hemodynamics and left ventricular function developed after AMI in rats, cardiomyocyte apoptosis occurred in the infarction/scar, border and non infarcted areas.Four weeks of carvedilol treatment could improve left ventricular function and reduce cardiomyocyte apoptosis in the scar and border areas.
出处 《中国循环杂志》 CSCD 北大核心 2004年第6期454-458,共5页 Chinese Circulation Journal
  • 相关文献

参考文献18

  • 1Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest, 1996,74(1):86-107.
  • 2Cheng W, Kajstura J, Nitahara JA, et al. Programmed myocyte cell death affects the viable myocardium after infarction in rats. Exp Cell Res, 1996,226(2):316-327.
  • 3Yue TL, Wang C, Romanic AM, et al. Staurosporine-induced apoptosis in cardiomyocytes: A potential role of Cas pase-3. J Mol Cell Cardiol, 1998,30(3):495-507.
  • 4Yang YJ, Tang YD, Ruan YM, et al. Comparative effects of carvedilol and losartan alone and in combination for preventing left ventricular remodeling after acute myocardial infarction in rats. Circ J, 2003,67(2):159-162.
  • 5Weisman HF BD, Mannisi JA, Weisfeldt ML,et al. Cellular mechanisms of myocardial infarct expansion. Circulation, 1988,78(1):186-201.
  • 6唐熠达,杨跃进,张沛,阮英茆,孙瑞成,李永利,田毅,周燕文,高润霖.微小剂量卡维地洛防治大鼠急性心肌梗死左室重构的实验研究[J].中华老年心脑血管病杂志,2001,3(5):334-337. 被引量:1
  • 7Pfeffer JM, Pfeffer MA, Braunwald E. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ Res, 1985,57(1):84-95.
  • 8Bialik S, Geenen DL, Sasson IE, et al. Myocyte apoptosis during acute myocardial infarction in the mouse localizes to hypoxic regions but occurs independently of p53. J Clin Invest, 1997,100(6):1363-1372.
  • 9Sam F, Sawyer DB, Chang DL, et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol, 2000,279(1):H422-428.
  • 10Cheng W LB, Kajstura J, Li P, et al. Stretch-induced programmed myocyte cell death. J Clin Invest, 1995,96(5):2247-2259.

二级参考文献11

  • 1Doughty RN.Whalley CA.Gamble G.et al.Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disase[J].J Am coll Cardiol.1997.29:1060-1066
  • 2Senior R.Basu S.Kinsey C.et al.Carvedilol prevents remodeling in patients with left ventricular dysfunction after acute myocardial infarction [J].Am Herat J.1999.137:646-652.
  • 3Bristow MR.Cilbert EM,Abraham WT.et al.Carvedilol produced doserelated improvements in left ventricular function and sruvival in subjects with chronic heart failure[J].Circulation.1996.94:2807-2816.
  • 4Olivetti G.Capasso JM,Meggs LG.et al.Cellular basis of chronic ventricular remodeling after mycoardial infarction in rats[J].Cir Res.1991.68:856-859.
  • 5Litwin SE,Katz S.Long term captopril treatment improves diastolic filling more than systolic performance in rats with large myocardial infarction[J].J Am Coll Cardiol.1996.28:773-781.
  • 6Kai Hu Gaudron P.Georg E.et al.Long-term effects of beta-adrenergic blocking agent treatment of hemodynamic funcation and left ventricular remodeling in rats with expreimental myocardial infarction[J].J Am Coll Cardiol.1998.31:692-700.
  • 7Packer M,Bristow MR.Cohn J.et al US Heart failure Study Group:the effect of carvedilol on morbidity and mortality in patients with chronic heart failure[J].N Engl J Med.1996.334:1349-1355.
  • 8Zamchetti A.Stalla A.Neural control of renin release[J].Clin Sci Mol Med.1975.48:215-223.
  • 9Vaughan DE.Pfeffer MA.ACEI and cardiovascular remodeling[J].Cardiovasc Res.1994.28:159-165.
  • 10Capornolla S.Febo O.Gnemmi M.et al.β-blockade therpay in chronic heart failure:diastolic function and mitral regurgitation improvement by cervedilol[J].Am Heart J.2000.139:596-608.

同被引文献9

  • 1冯其茂,杨祖福.心肌细胞坏死和凋亡与心肌梗死后心室重构[J].中国康复理论与实践,2007,13(1):59-60. 被引量:3
  • 2Akyurek LM ,Johnsson C, Lange D, et al. Tolerance induction ameliorates allograft vasculopathy in rat aortictransplants. Influence of Fas-mediated apoptosis. J Clin Invest, 1998,101:2889-2899.
  • 3Kajstura J, Cheng W, Reiss K, et al. Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. Lab Invest, 1996,74 : 86-107.
  • 4Otter I, Conus S, Ravn U, et al. The binding protein properties and biolog- ical activities of Bc122 and Bax in ceils exposed to apoptotic stimuli. J Bi- ol Chem, 1998,273:6110-6120.
  • 5Lam M, Dubyak G, Chen L, et al. Evidence that Bcl-2 represses apoptosisby regulating endoplasmic reticulum associated Ca fluxes. Proc Natl Acad Sci USA, 1994,91:6569-6573.
  • 6Misao J, Hayakawa Y, Ohno M, et al. Expression of Bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction. Circulation, 1996, 94 : 1506-1512.
  • 7Cheng W, Kajstura J, Nitahara JA, et al. Programmed myocyta cell death aftects the risble myocardium after infarction in rats. EXP Cell Res, 1996,226:316-327.
  • 8Krown KA, Page MT, Nguyen C, et al. Tumor necrosis factor alpha-in- duced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling Cascade in cardiac cell death. J Clin Invest, 1996,98:2854- 2865.
  • 9马中富,叶任高,罗斌,何建桂,马虹,高劲松.p53和Bcl-2基因mRNA在老年急性心肌梗死猝死者心肌细胞凋亡中作用的研究[J].中国危重病急救医学,2001,13(10):593-597. 被引量:10

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部